C5ORF30 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.844400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.259590E-01
Normal-vs-Stage2
2.939600E-01
Normal-vs-Stage3
4.726400E-01
Normal-vs-Stage4
1.754790E-01
Stage1-vs-Stage2
3.394800E-01
Stage1-vs-Stage3
5.668600E-01
Stage1-vs-Stage4
4.696000E-01
Stage2-vs-Stage3
9.947000E-01
Stage2-vs-Stage4
5.230500E-02
Stage3-vs-Stage4
3.679400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.968600E-01
Normal-vs-AfricanAmerican
4.026200E-01
Normal-vs-Asian
3.553000E-01
Caucasian-vs-AfricanAmerican
6.468400E-01
Caucasian-vs-Asian
6.628600E-01
AfricanAmerican-vs-Asian
5.728400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.962600E-01
Normal-vs-Female
2.822200E-01
Male-vs-Female
6.299600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.220600E-01
Normal-vs-Age(41-60Yrs)
2.598000E-01
Normal-vs-Age(61-80Yrs)
3.150000E-01
Normal-vs-Age(81-100Yrs)
3.141200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.306400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.939600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.666400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.009000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.347200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.436000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.606000E-01
Normal-vs-Daily Drinker
4.613800E-01
Normal-vs-Weekly Drinker
4.898200E-01
Normal-vs-Occasional Drinker
1.695220E-01
Normal-vs-Social Drinker
2.584600E-01
Non Drinker-vs-Daily Drinker
6.944200E-01
Non Drinker-vs-Weekly Drinker
7.417400E-01
Non Drinker-vs-Occasional Drinker
4.680200E-01
Non Drinker-vs-Social Drinker
2.281600E-01
Daily Drinker-vs-Weekly Drinker
9.918400E-01
Daily Drinker-vs-Occasional Drinker
3.525600E-01
Daily Drinker-vs-Social Drinker
6.004000E-01
Weekly Drinker-vs-Occasional Drinker
4.178400E-01
Weekly Drinker-vs-Social Drinker
6.717400E-01
Occasional Drinker-vs-Social Drinker
8.631700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.225390E-01
Normal-vs-Grade 2
4.874100E-02
Normal-vs-Grade 3
4.631700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.280400E-02
Grade 1-vs-Grade 3
8.024300E-02
Grade 1-vs-Grade 4
1.225390E-01
Grade 2-vs-Grade 3
8.827400E-01
Grade 2-vs-Grade 4
4.874100E-02
Grade 3-vs-Grade 4
4.631700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.131600E-01
Normal-vs-NonDiabetic
2.851200E-01
Diabetic-vs-NonDiabetic
5.204200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.470000E-01
Normal-vs-NoPancreatitis
3.163200E-01
Pancreatitis-vs-NoPancreatitis
4.185800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.437000E-01
Normal-vs-N1
3.090400E-01
N0-vs-N1
4.070400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.906780E-01
Normal-vs-TP53-NonMutant
4.404600E-01
TP53-Mutant-vs-TP53-NonMutant
3.941600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
